Correlation Between Mineralys Therapeutics, and Renalytix

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Renalytix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Renalytix into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and Renalytix AI, you can compare the effects of market volatilities on Mineralys Therapeutics, and Renalytix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Renalytix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Renalytix.

Diversification Opportunities for Mineralys Therapeutics, and Renalytix

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Mineralys and Renalytix is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Renalytix AI in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Renalytix AI and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Renalytix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Renalytix AI has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Renalytix go up and down completely randomly.

Pair Corralation between Mineralys Therapeutics, and Renalytix

If you would invest  1,252  in Mineralys Therapeutics, Common on December 30, 2024 and sell it today you would earn a total of  214.00  from holding Mineralys Therapeutics, Common or generate 17.09% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Mineralys Therapeutics, Common  vs.  Renalytix AI

 Performance 
       Timeline  
Mineralys Therapeutics, 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Mineralys Therapeutics, Common are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively conflicting basic indicators, Mineralys Therapeutics, unveiled solid returns over the last few months and may actually be approaching a breakup point.
Renalytix AI 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Renalytix AI has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong essential indicators, Renalytix is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Mineralys Therapeutics, and Renalytix Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mineralys Therapeutics, and Renalytix

The main advantage of trading using opposite Mineralys Therapeutics, and Renalytix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Renalytix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Renalytix will offset losses from the drop in Renalytix's long position.
The idea behind Mineralys Therapeutics, Common and Renalytix AI pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency